India’s InvITs market is set to triple to Rs 21 lakh crore AUM by 2030, driven by reforms, institutional investment, and ...

Q1 2026 Management View CEO William Ballhaus stated that Mercury Systems delivered Q1 results "ahead of our expectations with ...

Mastercard shows consistent 15% annual growth driven by expansion in consumer and commercial payments. See why MA stock is a ...

British money managers are reporting a jump in people withdrawing cash from their pensions before this month's budget, amid ...

Freshpet beats Q3 earnings with 14% revenue growth and positive cash flow. Discover if FRPT is a smart buy amid rising costs.

Q3 2025 Management View David Steinberg, Co-Founder, Chairman & CEO, stated, "For the 17th quarter in a row, we once again ...

Record quarterly revenue of $3.4 billion, up 8% year over year, with organic revenue growth of 4%Signed new business wins of $280 million, up 24% year over yearGenerated $232 million of operating cash ...

Despite beating on revenue and raising full-year guidance, shares of AXON dropped 20% in after hours trading following its Q3 ...

Cash flow is the lifeblood of any small business. If you notice your income and expenses fluctuating wildly each month, pay ...

Though there is no one-size-fits-all way to fund a company, one founder told Insider to think big about the possibilities.

CSL (ASX:CSL) has kicked off its US Capital Markets Day – actually a three-day fiesta of prezzos and site visits – with an upbeat take on the prospects of recovery for its Seqirus vaccine arm.

Kimberly-Clark is buying Tylenol maker Kenvue in an approximately $48.7 billion cash-and-stock deal, creating a massive consumer health goods company ...